Simulation as a preoperative planning approach in advanced heart failure patients. A retrospective clinical analysis by Capoccia, Massimo et al.
Simulation as a preoperative planning 
approach in advanced heart failure patients. 
A retrospective clinical analysis
Massimo Capoccia1,2, Silvia Marconi3, Sanjeet Avtaar Singh4, Domenico M. Pisanelli5 
and Claudio De Lazzari3,6* 
Background
Physiological fluid flow modelling using computational fluid dynamics (CFD) has 
increased our understanding of complex system interactions with particular reference 
to problem solving in a clinical environment [1–6]. Functional analysis and assessment 
of the cardiovascular system through computational modelling based on imaging tech-
niques has certainly received great attention in relation to its diagnostic value and plan-
ning approach [7–11].
Mathematical modelling and simulation may become clinically applicable tools for 
detailed evaluation of the cardiovascular system and clinical decision-making to guide 
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therapeutic intervention [12]. Models based on pressure–volume relationship and 
lumped-parameter representation of the cardiovascular system may be a suitable choice 
given their simplicity and versatility [13–19]. Although they provide less detailed pre-
dictions of pressure and flow waveforms, these models have shown great flexibility in 
simulating the haemodynamics of different cardiovascular conditions and therapeu-
tic interventions with the potential to be run in real time on desktop, laptop or mobile 
devices [12]. The successful clinical application of this approach requires further haemo-
dynamics teaching to the medical community although its importance is still far from 
being fully appreciated [19–21].
This approach has great potential for application in heart failure where the impact of 
left ventricular assist devices (LVADs) has played a significant role as a bridge to trans-
plant and more recently as a long-term solution for non eligible candidates. Continuous 
flow rotary blood pumps are currently the most popular devices because of their smaller 
size, increased reliability and higher durability compared to pulsatile-flow devices. The 
trend towards their use is increasing. Mathematical modelling and computer simulation 
are invaluable tools to investigate the interactions between LVADs and the cardiovascu-
lar system [22–24]. CFD simulations for continuous flow LVADs are usually performed 
under steady flow conditions where the inlet boundary is set to a specific steady veloc-
ity profile while the outlet boundary is fixed at a steady pressure. The actual unsteady 
boundary conditions will be dependent on the flow from the heart and the aortic pres-
sure, which are the result of the interactions between the device and the cardiovascular 
system [25]. The study of the interaction between LVADs and the whole cardiovascular 
system with a 3-D CFD model is highly demanding although specific parts of the assisted 
circulation have been developed with this method [26] but their practical application 
may be limited at present. A more simplified approach is based on one-dimensional 
(1-D) or lumped parameter (0-D) models where space dependence is either confined to 
the axial coordinate (1-D) or addressed by splitting the cardiovascular system in com-
partments (0-D) [27].
The native ventricular behaviour can be modelled according to the time-varying 
elastance theory [28–30], which remains a landmark despite its limitations [31] and 
previous criticism when applied to a mechanically supported left ventricle [32]. Signifi-
cant elastance changes are observed during circulatory support with a blood displace-
ment pump because of extreme and fast changing loading conditions. Therefore, the 
relationship between elastance and contractility may be no longer applicable when a 
second pump is connected to the systemic circulation [32]. Elastance changes are also 
observed with continuous flow pumps where an increasing pump flow is related to a 
constant end-systolic volume, a decrease in end-diastolic volume and a maximum left 
ventricular pressure increase with a gradual increase in the slope (Ees) of the end-sys-
tolic pressure–volume relationship (ESPVR) to justify dissociation between contractil-
ity and elastance [32]. Although a linear model has been proven sufficiently accurate 
[33–35] and adequate for realistic simulations of the instantaneous pressure–volume 
relation [36], recent multi-scale modelling of the cardiovascular system [37] based on 
previously developed approaches [38–40] has successfully addressed the limitations 
of the time-varying elastance theory with particular reference to load-dependence of 
ESPVR. Further modelling techniques can describe a failing cardiovascular system [41] 
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and ventricular interactions [42–44]. To address the shortcomings of the original time-
varying elastance theory, a nonlinear time-varying lumped parameter model of the car-
diovascular system [45] can be modified to include the inter-ventricular septum and a 
rotor-dynamic, continuous flow LVAD [46]. This is a more accurate heart failure model 
where the ESPVR is a unimodal function that takes into account the descending limb 
of the Frank–Starling curve, making it particularly suitable to study ventricular interac-
tions and the leftward septal shift secondary to left ventricular decompression following 
LVAD insertion. Outlet tube pump modelling with a linearly flow-dependent resistance 
is also used to study pulsatile and continuous flow LVADs. The resistance consists of 
flow-proportional and constant components in the context of a steady state environ-
ment but dynamic modelling with a time-varying resistance has been considered more 
recently [47, 48]. A Lagrange multiplier coupling approach [49] can be applied to LVAD 
modelling [50] using fictitious domain methods [51, 52] to address the interactions 
between the LVAD cannula and the ventricle at the expense of significant increase in 
computational time and instability in specific regions of interface between the fluid and 
solid meshes. To overcome these limitations, a fluid–solid left ventricular model cou-
pled with a 0-D Windkessel model [53, 54] already successfully applied to different types 
of LVAD [55–57] can be used where optimization with high order interpolation at the 
fluid–solid boundary allows simulations of fluid–solid interaction over a complete car-
diac cycle during LVAD support [58].
Following these considerations, we sought to investigate the value of simulation in the 
context of three heart failure patients previously discussed at a multidisciplinary meet-
ing with a view to predict or guide further management. The aim was to compare the 
outcome of the simulations with the previously made clinical decision in order to find 
out any relationship that may be applicable on a routine basis in future patient assess-
ment. The key elements would be:
  • A more targeted approach for different group of patients;
  • More quantitative evaluation in the clinical decision process;
  • The predictive value of simulation;
  • Preoperative planning and treatment optimisation.
Methods
We retrospectively analysed the haemodynamic data of three heart failure patients pre-
viously discussed at a multidisciplinary meeting and subsequently treated accordingly. 
Given the retrospective nature of this study, informed consent was waived [59]. The 
aim was to reproduce the preoperative haemodynamic status of these patients and then 
carry out simulations in the presence of a ventricular assist device in order to evaluate 
their suitability for prolonged mechanical support or other intervention.
The study was carried out using  CARDIOSIM©, which is a software package devel-
oped by the Cardiovascular Numerical Modelling LAB linked to the Institute of Clinical 
Physiology, CNR, Rome, Italy [60]. This is a numerical simulator of the cardiovascular 
system based on lumped parameter models, modified time-varying elastance and pres-
sure–volume analysis of ventricular function. The software is interactive and capable 
of reproducing physiological and pathological conditions for clinical decision-making 
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in a controlled environment [14, 15]. The main feature is a modular approach with an 
updatable library of numerical models of different sections of the cardiovascular system, 
which can be assembled according to the need of the simulation. The software is particu-
larly suitable to study the interactions with pulsatile or continuous flow ventricular assist 
devices [15, 22–24], intra-aortic balloon pump, artificial lung, biventricular assist device 
and biventricular pacing [15, 18, 61–63].
When the native atrial and ventricular behaviour are modelled, the numerical simula-
tor allows choosing between two different modules [16–19] based on the time-varying 
elastance theory. For the purpose of our simulations, we have considered the module 
where left and right ventricular elastances elv(t) and erv(t) are described as a function of 
the characteristic elastance in systole ( Elv,s and Erv,s ) and in diastole ( Elv,d and Erv,d ), and 
an activation function ( elv(t) and erv(t) ) as follows [54]:
where
T  is the duration of the ECG signal (heart period), TTE is the end of ventricular systole 
and TT is the T-wave peak time [15, 19].
Instantaneous left and right ventricular pressures Plv(t) and Prv(t) are obtained from 
the instantaneous ventricular free wall volumes and elastances as follows [54]:
where V ∗lv(t) and V ∗rv(t) are the instantaneous left and right ventricular free wall volumes; 
Vlv,0 and Vrv,0 are the resting left and right ventricular volumes; Plv,0 and Prv,0 are the 
resting left and right ventricular pressures.
The same approach is applicable to the atrial chambers, the interventricular (IVS) and 
interatrial (IAS) septum [15]. The IVS is the key factor where the properties of one ven-
tricle are a function of the contra-lateral one [64]. When the time-varying elastance the-
ory is applied, from Eq. (1) we obtain [15, 19]:
elv(t) = Elv,d +
[
Elv,s − Elv,d
2
]
· elv(t)
erv(t) = Erv,d +
[
Erv,s − Erv,d
2
]
· erv(t)
elv(t) = erv(t) =


1− cos
�
t
TT
pi
�
0 ≤ t ≤ TT
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�
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TTE−TT
pi
�
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(1)
Plv(t) = Plv,0 + elv(t) ·
[
V∗lv(t) − Vlv,0
]
Prv(t) = Prv,0 + erv(t) ·
[
V∗rv(t)− Vrv,0
]
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where eVsp(t) is the septal ventricular elastance described in [15, 19]. Vlv(t) and Vrv(t) 
represent the instantaneous left and right ventricular volume respectively.
Equation  (2) are essential for the model to simulate ventricular interactions with or 
without mechanical circulatory support.
Similarly, the following equations were used to reproduce the atrial behaviour [15, 
19]:
where eAsp(t) is the septal atrial elastance described in [15, 19]; ela(t) and era(t) are the 
left and right atrial elastances; Pla(t) [ Vla(t) ] and Pra(t) [ Vra(t) ] are the instantaneous 
left and right atrial pressures [volumes]; Vla,0 and Vra,0 are the resting left and right atrial 
volumes.
Equation (3) are essential for the model to simulate atrial interactions with or with-
out mechanical circulatory support.
The systemic arterial section consists of the aortic, thoracic and abdominal com-
partment and is modelled as described in [14, 65] with RLC circuits (Fig.  1). The 
whole venous system is modelled with only one RC circuit. The inertial forces have 
been neglected. The pulmonary arterial section consists of the main pulmonary artery 
and the intra-pulmonary vascular bed, each modelled with a RLC lumped element. 
The pulmonary arteriole compartment consists of a single resistance in view of their 
relative stiffness and the fact that inertial forces are negligible. The pulmonary capil-
lary section is also modelled with a single resistance as previously reported [18]. Cou-
pling between the ventricles and the circulation is obtained by using ideal valves [17, 
22]. The potential for research, clinical application and training is significant and well 
documented [14, 15, 21, 66].
Figure 2 shows the electric analogue of the LVAD model (Berlin Heart INCOR Pump) 
[55] integrated in the software and used for our simulations. The inlet and outlet cannu-
lae are modelled with RLC elements Rvpi, Lvpi,Cvpi and Rvpo, Lvpo,Cvpo.
(2)
Plv(t) =
[
eVsp(t) · elv(t)
elv(t)+ eVsp(t)
]
·
[
Vlv(t)− Vlv,0
]
+
[
elv(t)
elv(t)+ eVsp(t)
]
· Prv(t)+
[
eVsp(t)
elv(t)+ eVsp(t)
]
· Plv,0
Prv(t) =
[
eVsp(t) · erv(t)
eVsp(t)+ erv(t)
]
· [Vrv(t)− Vrv,0]
+
[
erv(t)
eVsp(t)+ erv(t)
]
· Plv(t)+
[
eVsp(t)
eVsp(t)+ erv(t)
]
· Prv,0
(3)
Pla(t) =
[
eAsp(t) · ela(t)
ela(t)+ eAsp(t)
]
·
[
Vla(t)− Vla,0
]
+
[
ela(t)
ela(t)+ eAsp(t)
]
· Pra(t)+
[
eAsp(t)
ela(t)+ eAsp(t)
]
· Pla,0
Pra(t) =
[
eAsp(t) · era(t)
eAsp(t)+ era(t)
]
· [Vra(t)− Vra,0]
+
[
era(t)
eAsp(t)+ era(t)
]
· Pla(t)+
[
eAsp(t)
eAsp(t)+ era(t)
]
· Pra,0
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The inlet and outlet cannulae flows Qvpi and Qvpo are calculated as follows:
{
(Plv + Pt)− Pvpi = Qvpi · Rvpi + Lvpi
dQvpi
dt
Qvpi = Qvad + Cvpi
dPvpi
dt
{
Pvpo − (Pas + Pt) = Qvpo · Rvpo + Lvpo
dQvpo
dt
Qvpo = Qvad − Cvpo
dPvpo
dt
Fig. 1 Electrical analogue model of the cardiovascular system. The systemic arterial section consists of three 
RLC elements representing the aortic  (RAT,  LAT and  CAT), thoracic  (RTT,  LTT and  CTT) and abdominal  (RABT,  LABT 
and  CABT) tract respectively. Ras is the variable systemic peripheral resistance. The systemic venous section 
consists of two variable resistances (Rvs1 and Rvs2) and a compliance (Cvs). The main (small) pulmonary 
section is reproduced by a RLC element: Rpam, Lpam and Cpam (Rpas, Lpas and Cpas). The arteriole 
(capillary) bed behaviour is reproduced by a single resistance Rpar (Rpc). The pulmonary venous section 
consists of a compliance (Cvp) and a resistance (Rvp). Pt is the mean intrathoracic pressure
Fig. 2 Electrical analogue model of the Berlin Heart INCOR pump. Plv ad Pas are the left ventricular and 
systemic arterial pressures respectively. Input (output) pump cannula is modelled with a resistance Rvpi 
(Rvpo), a compliance Cvpi (Cvpo) and an inertance Lvpi (Lvpo). Qvad is the pump flow and Qvpi (Qvpo) is the 
input (output) cannula flow
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where Pt is the mean intrathoracic pressure, Pas is the systemic atrial pressure, Pvpi and 
Pvpo are the inlet and outlet cannulae pressures.
The LVAD flow Qvad is described by:
where
A0 is the component of the LVAD speed; Ap is the amplitude of the pulsation compo-
nent; ε0 is the phase difference between the LVAD pulsation component and the native 
cardiac timing. The setting parameters are listed in Table 1.
The first order ordinary differential equations of the cardiovascular model were ini-
tially solved using both Euler’s and fourth order Runge–Kutta’s methods. The two 
numerical methods gave the same results under steady state conditions. The Euler’s 
method with a time step of 1 ms was preferred because of its lower computational cost 
compared to the Runge–Kutta’s method. The simulation software was written using Vis-
ual Basic language. Statistical analysis was carried out using the unpaired “t” test and 
correlation coefficients were calculated.
The retrospective analysis was performed on the haemodynamic data of the following 
patients:
Patient 1
A 34-year-old patient who sustained an extensive anterior wall myocardial infarction, 
which was initially treated with a percutaneous interventional procedure and the inser-
tion of a drug eluting stent to the left anterior descending coronary artery. Subsequently, 
stent occlusion and residual severe left ventricular systolic dysfunction with an ejection 
fraction of 27% required full anti-failure treatment. Further deterioration required dobu-
tamine infusion and close monitoring. The presence of co-morbidities, particularly high 
Qvad = Kvad,0 + ω · Kvad,1 + Kvad,2 ·
(
Pvpo − Pvpi
)
+ Kvad,3 · ω ·
(
Pvpo − Pvpi
)
+ Kvad,4 · ω
2
·
(
Pvpo − Pvpi
)
+ Kvad,5 · ω ·
(
Pvpo − Pvpi
)2
+ Kvad,6 · ω
2
·
(
Pvpo − Pvpi
)2
ω(t) = A0 + Ap · sin
(
2pi t
T
+ ε0
)
Table 1 Setting parameters of the LVAD used for the simulations
Parameter Value Unit
Inlet and outlet cannulae parameters
 Cvpi [ Cvpo] 0.1 [0.1] mmHg−1 ml
 Rvpi [ Rvpo] 0.01 [0.01] mmHg s/ml
 Lvpi [ Lvpo] 1.2 × 10−4 [1.2 × 10−4] mmHg s2/ml
LVAD parameter
 Kvad,1 − 3.0361 × 10−3 l/min/rpm
 Kvad,2 − 1.23045 l/min/mmHg
 Kvad,3 5.78974 × 10−4 l/min/rpm/mmHg
 Kvad,4 − 5.8777 × 10−8 l/min/rpm2/mmHg
 Kvad,5 − 1.27359 × 10−6 l/min/rpm/mmHg2
 Kvad,6 2.04834 × 10−10 l/min/rpm2/mmHg2
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body mass index (BMI), made this patient unsuitable for transplant while the insertion of 
a left ventricular assist device remained debatable and unlikely to be beneficial. Haemo-
dynamic data from repeated right heart catheter showed persistent elevated pulmonary 
artery pressures and resistance with significantly reduced right ventricular stroke work 
index, which increased the need for right ventricular support following LVAD insertion 
with potential for prolonged intensive care need and increased risk and complications. 
The final decision following a multidisciplinary team (MDT) meeting was to continue 
with medical management and palliative treatment. Table 2 shows measured haemody-
namic data following right heart catheterisation (RHC) on admission and 4 days later. 
End-diastolic ventricular volume [EDV = (CO/HR)/EF], end-systolic ventricular volume 
[ESV = EDV − (CO/HR)] and the slope (Ea) of arterial elastance (Ea ≈ BPmean/SV) [65], 
where SV is the stroke volume, were estimated from the measured parameters.
Patient 2
A 55-year-old patient with hypertrophic cardiomyopathy (NYH7 mutation), who pre-
viously underwent aortic valve replacement with a mechanical prosthesis and sub-
sequently percutaneous intervention to the left anterior descending coronary artery. 
Left ventricular ejection fraction  EFLeft was 45% in the context of chronic atrial fibrilla-
tion, previous ventricular arrhythmias and renal impairment. Symptoms deterioration 
required multiple hospital admissions with readjustment of anti-failure treatment and 
finally commenced on Milrinone (PDE3 inhibitor) infusion. A MDT meeting considered 
a LVAD not a suitable option and therefore this patient was placed on the transplant 
Table 2 Measurements following right heart catheterisation on admission (RHC 1) 
and after 4 days (RHC 2)
BP blood pressure, RA right atrial pressure, RV right ventricular pressure, PA pulmonary arterial pressure, PCWP pulmonary 
capillary wedge pressure, TPG trans-pulmonary pressure gradient, CO cardiac output, CI cardiac index, PVR pulmonary 
vascular resistance, RVSWI right ventricular stroke work index, HR heart rate, BSA body surface area, EFLeft left ventricular 
ejection fraction, EDV end-diastolic volume, ESV end-systolic volume, Ea arterial elastance
Patient #1 RHC 1 (admission) RHC 2 (after 4 days)
Max Min Mean Max Min Mean
BP (mmHg) 85–90 59 69.3 85–90 60 70
RA (mmHg) 35 17 29 38 22 32
RV (mmHg) 61 14 38 71 11 44
PA (mmHg) 62 30 42 70 38 50
PCWP (mmHg) 36 31 32 35 25 34
TPG (mmHg) 10 16
CO (l/min) 2.7 2.8
CI (l/min/m2) 1.36 1.4
PVR (wood unit) 3.7 5.7
RVSWI (g/m2/beat) 2.4 2.4
HR (bpm) 100 95
BSA  (m2) 1.98 1.98
EFLeft (%) 27 27
Estimated values
EDV (ml) ~ 100 ~ 109
ESV (ml) ~ 73 ~ 80
Ea (mmHg/ml) ~ 3.0 ~ 2.8
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Table 3 Measurements following right heart catheterisation on admission (RHC 1), 
after 1 month (RHC 2) and after 2 months (RHC 3)
BP blood pressure, RA right atrial pressure, RV right ventricular pressure, PA pulmonary arterial pressure, PCWP pulmonary 
capillary wedge pressure, TPG trans-pulmonary pressure gradient, CO cardiac output, CI cardiac index, PVR pulmonary 
vascular resistance, RVSWI right ventricular stroke work index, HR heart rate, BSA body surface area, EFLeft left ventricular 
ejection fraction, EDV end-diastolic volume, ESV end-systolic volume, Ea arterial elastance
Patient #2 RHC 1 (admission) RHC 2 (after 1 month) RHC 3 (after 2 months)
Max Min Mean Max Min Mean Max Min Mean
BP (mmHg) 95–100 58 72 – – – – – –
RA (mmHg) 14 2 9 10 4 6 11 1 7
RV (mmHg) 39 2 17 37 1 15 32 -2 14
PA (mmHg) 40 17 27 34 15 26 31 14 22
PCWP (mmHg) 28 7 18 26 8 15 26 11 15
TPG (mmHg) 9 11 7
CO (l/min) 5.3 7.1 5.6
CI (l/min/m2) 2.26 3.02 2.4
PVR (wood unit) 1.7 1.55 1.25
RVSWI (g/m2/beat) 8.5 9.35 6.2
HR (bpm) 65 88 78
BSA  (m2) 2.35 2.35 2.35
EFLeft (%) 45 – –
Estimated values
EDV (ml) ~ 181 – –
ESV (ml) ~ 99 – –
Ea (mmHg/ml) ~ 1.1 – –
Table 4 Measurements following right heart catheterisation on admission (RHC 1), 
after 15 days (RHC 2) and after 22 days (RHC 3)
BP blood pressure, RA right atrial pressure, RV right ventricular pressure, PA pulmonary arterial pressure, PCWP pulmonary 
capillary wedge pressure, TPG trans-pulmonary pressure gradient, CO cardiac output, CI cardiac index, PVR pulmonary 
vascular resistance, RVSWI right ventricular stroke work index, HR heart rate, BSA body surface area, EFLeft left ventricular 
ejection fraction, EDV end-diastolic volume, ESV end-systolic volume, Ea arterial elastance
Patient #3 RHC 1 (admission) RHC 2 (after 15 days) RHC 3 (after 22 days)
Max Min Mean Max Min Mean Max Min Mean
BP (mmHg) 100 60 73.3 – – – – – –
RA (mmHg) 14 12 9 18 11 15 14 6 10
RV (mmHg) 53 5 – 60 4 28 67 -3 28
PA (mmHg) 58 27 37 75 33 44 75 36 48
PCWP (mmHg) 39 29 31 48 26 35 47 26 33
TPG (mmHg) 6 9 15
CO (l/min) 4.2 4.5 2.6
CI (l/min/m2) 1.94 2.1 1.2
PVR (wood unit) 1.4 2 6.8
RVSWI (g/m2/beat) 9.87 11.4 9.15
HR (bpm) 75 72 68
BSA  (m2) 2.16 2.16 2.16
EFLeft (%) 15 – –
Estimated values
EDV (ml) ~ 373 – –
ESV (ml) ~ 317 – –
Ea (mmHg/ml) ~ 1.6 – –
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list. Table  3 shows measured and estimated haemodynamic data on admission, 1 and 
2 months later.
Patient 3
A 52-year-old patient who previously sustained a myocardial infarction requiring cor-
onary artery bypass grafting and subsequently implantable cardioverter defibrillator 
(ICD) insertion because of ventricular arrhythmias. Significant deterioration of the clini-
cal picture had already required multiple hospital admission in a background of dilated 
left ventricle (left ventricular end-diastolic diameter 8.1  cm) with severe systolic (left 
ventricular ejection fraction 15%) and diastolic dysfunction (E/A ratio 3.4) and severe 
pulmonary hypertension. Finally, Milrinone and diuretic infusion were commenced and 
an intra-aortic balloon pump was inserted. Following a MDT meeting, this patient was 
listed for transplant with a view to LVAD insertion if further deterioration occurred. 
Table  4 shows measured and estimated haemodynamic data on admission, 15 and 
22 days later.
Table 5 Comparison between measured and simulated parameters for patient 1 
on admission
BP blood pressure, RA right atrial pressure, RV right ventricular pressure, PA pulmonary arterial pressure, PCWP pulmonary 
capillary wedge pressure, TPG trans-pulmonary pressure gradient, CO cardiac output, CI cardiac index, PVR pulmonary 
vascular resistance, RVSWI right ventricular stroke work index, HR heart rate, BSA body surface area, EFLeft left ventricular 
ejection fraction, EDV end-diastolic volume, ESV end-systolic volume, Ea arterial elastance, Ees slope of end-systolic 
pressure–volume relationship (ESPVR)
Patient #1 Measured (RHC 1) Simulation (RHC 1) LVAD (simulation)
Max Min Mean Max Min Mean Max Min Mean
BP (mmHg) 85–90 59 69.3 87.2 60.7 69.3 75.2 62.9 68.2
RA (mmHg) 35 17 29 10.5 3.5 6.5 10.3 3.5 6.5
RV (mmHg) 61 14 38 44.2 8.0 20.4 43.5 8.0 20.1
PA (mmHg) 62.0 30.0 42.0 44.0 39.7 42.0 43.3 38.7 40.9
PCWP (mmHg) 36.0 21.0 32.0 31 18.7 25.0 29.6 16.8 23.1
HR (bpm) 100 100 100
EFLeft (%) 27 26.9 31.4
BSA  (m2) 1.98 1.98 1.98
CO (l/min) 2.7 2.7 COVENTR 0.67
QVAD 2.15
TOT 2.82
CI (l/min/m2) 1.36 1.36 0.34
TPG (mmHg) 10 17 18
PVR (wood unit) 3.7 6.3 26.87 (18.0/0.67)
6.38 (18.0/2.15)
RVSWI (g/m2/beat) 2.4 6.53 6.86
Estimated Simulated Simulated
EDV (ml) ~ 100 100.4 89.76
ESV (ml) ~ 73 73.4 61.57
Ea (mmHg/ml) ~ 3.0 3.2 2.6
Ees (mmHg/ml) – 0.88 0.88
Ea/Ees – 3.64 2.95
Page 11 of 21Capoccia et al. BioMed Eng OnLine  (2018) 17:52 
The diseased status for each patient was reproduced starting from the measured 
parameters. Subsequently, LVAD support without and with drug administration (Mil-
rinone) was applied to each patient. The effects induced by Milrinone administration 
were simulated with the aim to increase heart contractility by 10% and reduce pulmo-
nary and systemic resistances by 10%.
Results
Table 5 shows (for the first patient) the comparison between measured (second column) 
and simulated parameters (third column) for “Admission” conditions. In simulated con-
ditions, the simulator calculates the slope Ees of the end-systolic pressure–volume rela-
tionships (ESPVR) and the ratio Ea/Ees. In normal conditions, Ea/Ees ratio represents a 
reliable index of ventricular–arterial coupling. The estimated and simulated Ea are simi-
lar. The last column of the table shows simulated values during LVAD assistance. EDV, 
ESV and SV decreased with a leftward shift of the left ventricular loop (in the pressure–
volume plane) during LVAD support. Moreover, Ea decreased from 3.2 (mmHg/ml) to 
2.6 (mmHg/ml) and the Ea/Ees ratio decreased from 3.64 to 2.95 during assistance. Two 
different values for PVR are reported in Table 5: the first one is calculated as the ratio 
between TPG and left ventricular output flow  (COVENTR), the second one is calculated as 
the ratio between TPG and LVAD flow  (QVAD).
Table 6 shows (for the second patient) the comparison between measured (second col-
umn) and simulated parameter (third column) for “Admission” conditions. The third and 
fourth columns represent two different simulated assisted conditions. The first one is 
obtained applying LVAD support, the second is obtained applying LVAD support and 
considering the effects induced by Milrinone. Figure 3 shows a screen output produced 
by our simulator when LVAD support was applied on the simulated “Admission” condi-
tion. In the left ventricular pressure–volume plane, the upper window shows the ven-
tricular loop in “Admission” conditions (loop A) and the ventricular loop obtained when 
LVAD support was applied (loop B). In addition, Fig. 3 shows that the arterial elastance 
changes as reported in Table 6 where the Ea/Ees ratio decreases from 1.62 to 1.32 when 
LVAD support is applied. When the effects induced by the simultaneous presence of 
LVAD and pharmacological treatment are simulated, left ventricular ejection fraction 
 EFLeft increases from 45.1% (“Admission” conditions) to 55.9% and the Ea/Ees ratio 
decreases from 1.62 (“Admission” conditions) to 1.20. LVAD assistance and Milrinone 
administration reduce EDV and ESV (Table  6). EDV and ESV reduction induced by 
LVAD support only is shown in Fig. 3 where a leftward shift of the left ventricular loop is 
observed.
Finally, Table  7 shows the simulation results of the third patient. Again, the Ea/Ees 
ratio decreased when LVAD support and Milrinone administration were simultaneously 
applied. Table 7 shows that LVAD support produces a leftward shift of the left ventricu-
lar loop in the pressure–volume plane reducing EDV and ESV.
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Discussion
Cardiovascular modelling has been very successful in increasing our knowledge of physi-
ological mechanisms where simplified representations of complex biological systems can 
be used to study their behaviour at different levels [67]. The Cardiac Physiome project 
is currently the most ambitious and successful application of mathematical and compu-
tational modelling aimed to advance our understanding of physiology using a quantita-
tive multi-scale approach [67, 68]. Cardiovascular modelling has now reached the stage 
where clinical application in the form of patient-specific modelling may become a daily 
routine in a non distant future. For this approach to become reality, a model must be 
reliable, reproducible and reduce uncertainty [67, 68]. While effective in the laboratory, 
almost all the decision support tools have failed when applied to clinical practice [69]. 
Therefore, it is essential to overcome skepticism by developing a strong, realistic model 
that can fulfil the expectations. Our approach is focused on modelling and simulation 
not as a substitute for clinical experience but as an additional tool to guide therapeu-
tic intervention or predict clinical outcome: the clinician will be the ultimate decision 
maker. The development of a comprehensive, integrated model of the cardiovascular 
Fig. 3 Screen output obtained using our simulator. The first step consists of simulating the “Admission” 
conditions of the second patient. Subsequently, LVAD assistance is applied. The upper window shows the 
simulated starting ventricular loop (A) and the ventricular loop obtained during LVAD assistance (B) in the left 
ventricular pressure–volume plane. The mean values (calculated during the cardiac cycle in the presence of 
LVAD assistance) of pressure, flow and HR are reported in the right column. Mean systolic and diastolic values 
are reported for the systemic arterial pressure (Pas ≡ BP). Pla is the mean left atrial pressure (Pla ≡ PCWP). Pra is 
the mean right atrial pressure. Mean pulmonary arterial pressure (Ppam ≡ PA), systemic venous pressure (Pvs) 
and pulmonary venous pressure (Pvp) are also shown. In the bottom column, mean left/right atrial input 
flow (Qlia/Qria), left/right ventricular input flow (Qli/Qri) and right ventricular output flow (Qro) assume the 
same value. The sum of the mean left ventricular output flow (Qlo) and the Qvad (LVAD flow) equals the flow 
into the circulatory network (Qlo + Qvad = Qlia = Qria = Qro = Qri = Qli). Finally, the left lower box reports 
the end-systolic volume (Ves ≡ ESV), the end-diastolic volume (Ved ≡ EDV), the stroke volume (SV) and the 
ejection fraction (EF) for both ventricles
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system based on lumped-parameter models, modified time-varying elastance and pres-
sure–volume analysis of ventricular function is an attractive prospect with a view to 
clinical application. The differential equations describing such a model can be solved 
relatively easy and yield answers in terms of pressure–volume loops and time-depend-
ent tracings of pressure, flow and volume that may well help the decision process and 
management in the clinical setting.  CARDIOSIM© fulfils these requirements although 
we acknowledge that other software such as CircAdapt Simulator, HemoLab and Harvi 
may be potentially suitable for clinical application. The CircAdapt Simulator is based on 
the CircAdapt model [70–72], which has been designed to simulate the dynamics of the 
heart and the circulation with the inclusion of a realistic relationship between pressure–
volume load and tissue mechanics where the geometry of the components is obtained 
by adaptation to mechanical load. The implementation of the TriSeg model [73] ena-
bles realistic simulation of ventricular mechanics including interactions between left and 
right ventricle, dynamics of septal geometry and myofibre mechanics in the three ven-
tricular walls. The interesting feature of the CircAdapt model is its combined adaptation 
of heart and vessels over a relatively long period of time resulting in self-structuring of 
the circulation as a system where a steady-state solution is obtained [74, 75]. This feature 
makes the model a potential tool for clinical application with the aim of predicting the 
evolution of a diseased status and the effects of an interventional procedure [67, 71, 72, 
76, 77] but there is a lack of suitable models for VADs support. Despite its limitations, 
the CircAdapt model is considered easy to use, requires relatively low computational 
time and allows realistic simulations of the circulation with boundary conditions suit-
able for more complicated models based on finite element analysis. HeMoLab (Haemo-
dynamics Modelling Laboratory) is an integrated computational environment for the 
modelling of the cardiovascular system. It is an effective research tool and a virtual sim-
ulation laboratory [78–80]. HeMoLab consists of a combination of models, which can 
be coupled locally and globally in order to obtain the systemic response of the cardio-
vascular system: the so called 3-D, 1-D and 0-D models. The propagation of the arte-
rial pulse is represented with a 1-D and 0-D model, which describes the behaviour of 
the flow rate, mean pressure and cross-sectional area as a function of time. HeMoLab 
is a suitable environment for the simulation of the effects of aging, vasodilatation, vaso-
constriction, rest and exercise and calculation of characteristic impedance of the arterial 
network. Although attractive, the software remains confined to a research environment 
at present. Harvi is an interactive simulation textbook of cardiovascular physiology and 
haemodynamics based on a previously described electrical circuit [81–83] where ven-
tricular and atrial contraction are represented by a modified time-varying elastance 
approach [12].
A simulation-based approach as a potential preoperative strategy in the context of 
patient-specific modelling in advanced heart failure may be an additional tool to obtain 
accurate predictions of device performance in a clinical setting with treatment opti-
misation of this complex and challenging group of patients [21]. Patients in advanced 
heart failure are critical and their management can be very demanding with emotion 
running high when dealing with younger patients. Patient 1 is a typical example of dif-
ficult case experienced by one of the authors (MC). Co-morbidities do play a role and 
must be taken into account during the multidisciplinary team meeting. The clinical cases 
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considered are typical heart failure patients referred for assessment for transplant or 
LVAD insertion. The outcome of the simulations is quite stimulating and open to debate.
The simulation outcome for patient 1 does show a leftward shift of the pressure–vol-
ume loops for the left and right ventricles with adequate ventricular volumes, although 
the gain in ejection fraction may be initially limited. On the contrary, it is true that 
further improvement is observed over a period of time [84] making LVAD insertion a 
suitable option for this patient. Because of the potential complications related to the 
associated co-morbidities, the unanimous clinical decision to decline any further inter-
vention but continue with medical treatment and eventually palliation may have been 
the way forward although further argument in favour of LVAD insertion would be the 
recent evidence supporting the “obesity paradox” in cardiac surgery [85], which is cur-
rently the subject of a hot debate.
Simulation of the baseline haemodynamic status for patient 2 shows comparable mean 
values with those measured during right heart catheter. VAD support shows improved 
left ventricular ejection fraction with some reduction in pulmonary artery pressures. 
The outcome for patient 3 is most beneficial with significant reduction of pulmonary 
artery pressures confirming the primary indication for VAD support to achieve pulmo-
nary haemodynamics compatible with transplantation.
In view of its features,  CARDIOSIM© may be a more suitable choice with particular 
reference to the effects of mechanical circulatory support on the cardiovascular system. 
Lumped-parameter models assume a uniform distribution of pressure, volume and flow 
within any specific compartment at any instant in time while higher dimensional models 
recognise the variation in space of these parameters. Lumped-parameter models con-
sist of simultaneous ordinary differential equations complemented by an algebraic bal-
ance equation and are suitable for examination of global distribution of pressure, flow 
and volume over a range of physiological conditions with inclusion of the interaction 
between modelled components. Higher dimensional models consist of partial differen-
tial equations complemented by balance equations. 1-D models represent wave trans-
mission effects within the vascular system but 3-D numerical solutions are required for 
complex flow patterns with analytical solutions obtained only for the simplest geometry 
[86]. A single-branch multiple compartment model of the vascular system is suitable for 
the evaluation of short-term VAD support compared to an overly detailed vessel branch 
model where parameter setting becomes quite difficult. Higher level lumped-parameter 
modelling is required to address the interaction between the circulation and other sys-
tems but a compromise between complexity and ability to set the required parameters is 
needed to personalise an integrated lumped model for a patient-specific approach.
CARDIOSIM© does address the systems interaction with its modular approach and 
assembly of models with varying degree of complexity although 0-D and 1-D coupling 
may be required for the evaluation of long-term VAD support.
During our simulations, we have also considered the effect on ventricular–arterial 
coupling following LVAD support. Age-related vascular stiffening and the concomitant 
changes in left ventricular diastolic compliance are frequently observed in heart failure 
with preserved ejection fraction and in aortic valve stenosis [87]. Ventricular–arterial cou-
pling is strictly related to cardiovascular performance and can be accurately quantified in 
terms of pressure and volume. The left ventricle and the arterial system are considered 
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elastic chambers with known volume elastances where left ventricular performance is 
measured by Ees, which is the slope of the ESPVR while the arterial system is measured 
by its elastance Ea, which is the slope of the arterial end-systolic pressure–stroke volume–
effective arterial elastance relationship [65, 87]. The Ea/Ees ratio may be considered as a 
reliable performance index for ventricular–arterial coupling. An Ea/Ees ratio close to 1 
relates to appropriate coupling between the left ventricle and the arterial system. Impaired 
coupling occurs in heart failure where Ees decreases following left ventricular systolic dys-
function and Ea is increased because of elevated impedance and reduced compliance [87]. 
Our simulations show that LVAD assistance can achieve appropriate ventricular–arterial 
coupling with an Ea/Ees ratio close to 1. The potential of this parameter may well justify 
further study for its routine clinical application in heart failure patients.
In summary, a simulation setting may well add a more quantitative approach to help 
the whole process, generate more critical thinking and perhaps give reassurance. The 
clinical scenarios discussed in this article are only an example of how the subject can be 
further developed and used as part of a preoperative planning strategy. Further work is 
currently being undertaken by our group and the outcome is awaited.
Conclusion
Although previous experience, co-morbidities and the risk of potentially fatal complica-
tions play a role in the clinical decision process, a simulation setting may well add a more 
quantitative approach and perhaps reassurance even if the clinician remains the ultimate 
decision-maker. Interactive software like  CARDIOSIM© can reproduce physiological 
and pathological conditions for clinical decision-making in a controlled environment. 
Its modular approach and versatility combined with the high availability of physiologi-
cal and pathological set up make it suitable for clinical application with particular refer-
ence to the evaluation of the effects of interventional procedures on the cardiovascular 
system such as the interactions with pulsatile and continuous flow VADs and the intra-
aortic balloon pump (IABP).
The development of an integrated model of the cardiovascular system based on 
lumped-parameter representation, modified time-varying elastance and pressure–vol-
ume analysis of ventricular function seems a feasible and suitable approach yielding a 
sufficiently accurate quantitative analysis in real time. The challenge remains the ability 
to predict outcome over a longer period of time.
Patient-specific modelling may become a daily approach for clinical management and 
optimisation of device treatment. Willingness to adopt such an integrated approach may 
be the key to further progress.
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output flow (l/min); Qri: mean right ventricular input flow (l/min); Qria: mean right atrial input flow (l/min); Qro: mean 
right ventricular output flow (l/min); QTT : thoracic tract flow (l/min); Qvad: LVAD flow (l/min); Qvpi: inlet LVAD can-
nula flow (l/min); Qvpo: outlet LVAD cannula flow (l/min); RA: right atrial pressure (mmHg); RAT : aortic tract resistance 
(mmHg s/ml); RABT : abdominal tract (mmHg s/ml); Ras: systemic peripheral resistance (mmHg s/ml); RHC: right 
heart catheterisation; RLC: resistor, inductor, capacitor; Rpam: main pulmonary section resistance (mmHg s/ml); Rpar
: arteriole resistance (mmHg s/ml); Rpas: small pulmonary section resistance (mmHg s/ml); Rpc: capillary resistance 
(mmHg s/ml); RTT : thoracic tract resistance (mmHg s/ml); RV: right ventricle pressure (mmHg); Rvp: pulmonary venous 
resistance (mmHg s/ml); Rvpi: inlet pump cannula resistance (mmHg s/ml); Rvpo: outlet pump cannula resistance 
(mmHg s/ml); Rvs1: venous system resistance (mmHg s/ml); Rvs2: venous system resistance (mmHg s/ml); RVSWI: right 
ventricular stroke work index (g/m2/beat); SV: stroke volume (ml); T : duration of the ECG signal (s); TPG: trans-pulmonary 
pressure gradient (mmHg); TTE: end of ventricular systole in the ECG signal (s); TT : t-wave peak time in the ECG signal 
(s); VAD: ventricular assist device; Ved: end-diastolic volume (ml); Ves: end-systolic volume (ml); Vla(t): left atrial volume 
(ml); Vla,0: resting left atrial volume (ml); Vlv(t): left ventricular volume (ml); Vlv,0: resting left ventricular volume (ml); 
V ∗lv(t): left ventricular free wall volume (ml); Vra(t): right atrial volume (ml); Vra,0: resting right atrial volume (ml); 
Vrv(t): right ventricular volume (ml); Vrv,0: resting right ventricular volume (ml); V
∗
rv(t): right ventricular free wall 
volume (ml).
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